Incidence of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome (ACS)

Authors

  • Noor Ali Department of Cardiology, Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta, Pakistan
  • Abdul Ghaffar Khan Department of Cardiology, Bolan Medical Complex Hospital, Quetta, Pakistan
  • Rahat Shah Department of Cardiology, Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta, Pakistan
  • Abdul Ali Department of Cardiology, Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta, Pakistan
  • Alexander Arshad Department of Cardiology, Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta, Pakistan
  • Arwan Ali Department of Cardiology, Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i7.2484

Keywords:

Atrial Fibrillation, Acute Coronary Syndrome, Incidence, Risk Factors.

Abstract

Background: Atrial fibrillation (AF) is one of the most common arrhythmias associated with acute coronary syndrome (ACS). Whether newly developed AF in the context of ACS is deleterious to hemodynamic stability, increases the risk of complications, or raises the chance of fatality remains uncertain. Identifying the incidence of AF, as well as the relevant risk factors, is essential to enhancing prompt management and clinical outcomes. Objectives: Establishing the incidence of new-onset atrial fibrillation in patients with acute coronary syndrome while assessing the relationships of associated clinical-demographic variables and in-hospital outcomes. Study Design: A cross-sectional study. Place and duration of study. Cardiology Department Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta, from December 2024 to May 2025. Methods: In the cardiology department a cross-sectional study involving 120 patients admitted with a primary diagnosis of acute coronary syndrome was undertaken. Individual demographic and clinical details were systematically recorded. During the hospitalization, the patients' electrocardiograms were monitored to identify possible new-onset atrial fibrillation. The analysis was conducted with the SPSS software, version 24.0. For the study variables, averages and standard deviations were determined, and the relationships between variables were tested using chi-square, and t-test procedures with an alpha of 0.05. Results: The 120 patients with Anterior Cardiac Syndrome had an age average of 59.3 ± 10.8 years. There were 70 (58.3%) men and 50 (41.7%) women. During their hospital stay, 11 patients (9.2%) present with new onsets of AF. The patients suffering from AF had a statistically significant Lower left ventricle ejection fraction (42.1 ± 7.9%) as compared to patients without AF (50.6 ± 8.3%, p = 0.004). Older age and increased serum creatinine levels were also statistically significant (p = 0.032 and p = 0.018). Conclusion: About 9% of patients with acute coronary syndrome develop new-onset atrial fibrillation which relates significantly to advanced age, kidney disease, and lower left ventricular ejection fractions. The complications of atrial fibrillation in the setting of acute coronary syndrome require aggressive recognition and management to reduce the risk of thrombosis and improve the short- and long-term outcomes of the patients.

Downloads

Download data is not yet available.

References

1. Ben Halima M, Yaakoubi W, Boudiche S, Rekik B, Zghal Mghaieth F, Ouali S, et al. New-onset atrial fibrillation after acute coronary syndrome: prevalence and predictive factors. La Tunisie medicale. 2022;100(2):114-21.

https://doi.org/10.1016/j.acvdsp.2020.10.328

2. Buckley BJR, Harrison SL, Hill A, Underhill P, Lane DA, Lip GYH. Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke. Stroke. 2022;53(5):1759-63.

https://doi.org/10.1161/strokeaha.121.037316

3. Hurskainen M, Tynkkynen J, Eskola M, Lehtimäki T, Hernesniemi J. Risk Factors for Ischemic Stroke After Acute Coronary Syndrome. Journal of the American Heart Association. 2023;12(14):e028787.

https://doi.org/10.1161/jaha.122.028787

4. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1-e156.

https://doi.org/10.1161/cir.0000000000001207

5. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2024;83(1):109-279.

https://doi.org/10.1161/cir.0000000000001263

6. Khanal RR, Gajurel RM, Shah S, Poudel CM, Shrestha H, Devkota S, et al. Arrhythmias: Its Occurrence, Risk Factors, Therapy, and Prognosis in Acute Coronary Syndrome. Journal of Nepal Health Study Council. 2023;21(1):8-14.

https://doi.org/10.33314/jnhrc.v21i1.4019

7. López-Palop R, Carrillo P, Lozano Í. Transient new-onset atrial fibrillation during acute coronary syndrome: Transient arrhythmia, transient risk? International journal of cardiology. 2024;410:132163.

https://doi.org/10.1016/j.ijcard.2024.132163

8. Naser JA, Pislaru SV, Stan MN, Lin G. Incidence, Risk Factors, and Outcomes of Incident Atrial Fibrillation in Patients With Graves Disease. Mayo Clinic proceedings. 2023;98(6):883-91.

https://doi.org/10.1016/j.mayocp.2022.12.013

9. Rankinen J, Hernesniemi J, Tynkkynen JT. Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications. Heart (British Cardiac Society). 2025.

https://doi.org/10.1136/heartjnl-2025-326003

10. Zhang H, Zheng L, Yang Z, Zhao H, Zhu Y, Ma Y, et al. Development and Validation of Prognostic Models for Bleeding and Ischemia in Elderly Patients With Comorbid Acute Coronary Syndrome and Atrial Fibrillation. Journal of the American Heart Association. 2024;13(20):e035086.

https://doi.org/10.1161/jaha.124.035086

11. Bazoukis G, Hui JMH, Saplaouras A, Efthymiou P, Vassiliades A, Dimitriades V, et al. The impact of new-onset atrial fibrillation in the setting of acute coronary syndrome. Journal of cardiology. 2025;85(3):186-203.

https://doi.org/10.1016/j.jjcc.2024.12.007

12. Jameie M, Rezaee M, Pashang M, Jalali A, Khalaji A, Behnoush AH, et al. Factors Affecting Late Atrial Fibrillation and Its Association With Coronary Artery Bypass Outcomes. The Annals of thoracic surgery. 2024;117(6):1145-52.

https://doi.org/10.1016/j.athoracsur.2024.02.007

13. Lopes RD, Guimarães PO, Schwartz GG, Bhatt DL, Bittner VA, Budaj A, et al. Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial. The American journal of medicine. 2022;135(7):915-8.

https://doi.org/10.1016/j.amjmed.2022.02.016

14. Narasimhan B, Patel N, Chakraborty S, Bandyopadhyay D, Sreenivasan J, Hajra A, et al. Impact of Atrial Fibrillation on Acute Coronary Syndrome-Analysis of In-Hospital Outcomes and 30-Day Readmissions. Current problems in cardiology. 2021;46(4):100764.

https://doi.org/10.1016/j.cpcardiol.2020.100764

15. Noubiap JJ, Agbaedeng TA, Nyaga UF, Lau DH, Worthley MI, Nicholls SJ, et al. Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients. Journal of cardiovascular electrophysiology. 2022;33(3):414-22.

https://doi.org/10.1111/jce.15351

16. Pernod G, Cohen A, Mismetti P, Sanchez O, Mahé I. Cancer-related arterial thromboembolic events. Archives of cardiovascular diseases. 2024;117(1):101-13.

https://doi.org/10.1016/j.acvd.2023.11.007

17. Pyka Ł, Hudzik B, Bartuś S, Buszman P, Gierlotka M, Wojakowski W, et al. Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality. Journal of cardiovascular pharmacology and therapeutics. 2023;28:10742484231212106.

https://doi.org/10.1177/10742484231212106

18. Tomasdottir M, Held C, Hadziosmanovic N, Westerbergh J, Lindbäck J, Aylward PE, et al. Risk markers of incident atrial fibrillation in patients with coronary heart disease. American heart journal. 2021;233:92-101.

https://doi.org/10.1016/j.ahj.2020.12.016

19. Wu N, Li J, Xu X, Yuan Z, Yang L, Chen Y, et al. Prediction Model of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome. International journal of clinical practice. 2023;2023:3473603.

https://doi.org/10.1155/2023/3473603

20. Yao C, Qin Y, Yan X, Zhao Z, Wang B, Bai Y, et al. Correlation between triglyceride-glucose index and atrial fibrillation in acute coronary syndrome patients: a retrospective cohort study and the establishment of a LASSO-Logistic regression model. BMC cardiovascular disorders. 2024;24(1):702.

https://doi.org/10.1186/s12872-024-04385-x

Downloads

Published

2025-07-15

How to Cite

Ali, N., Khan, A. G., Shah, R., Ali, A., Arshad, A., & Ali, A. (2025). Incidence of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome (ACS). Indus Journal of Bioscience Research, 3(7), 1225-1229. https://doi.org/10.70749/ijbr.v3i7.2484